We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+11.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$7.81B
AUM Growth
+$540M
Cap. Flow
-$59.7M
Cap. Flow %
-0.76%
Top 10 Hldgs %
4.74%
Holding
3,067
New
528
Increased
1,137
Reduced
1,133
Closed
263

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$48.4M
2
AAPL icon
Apple
AAPL
+$40.9M
3
PYPL icon
PayPal
PYPL
+$33.6M
4
CB icon
Chubb
CB
+$30.7M
5
ILMN icon
Illumina
ILMN
+$28.5M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$36M
2
LMT icon
Lockheed Martin
LMT
+$31.4M
3
CDW icon
CDW
CDW
+$31.3M
4
DHI icon
D.R. Horton
DHI
+$27.4M
5
FIS icon
Fidelity National Information Services
FIS
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 17.29%
2 Consumer Discretionary 15.76%
3 Healthcare 14%
4 Financials 13.56%
5 Industrials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNQ icon
2776
Canadian Natural Resources
CNQ
$97.3B
$15K ﹤0.01%
978
-13,085
-93% -$177K
NGNE icon
2777
Neurogene
NGNE
$714M
$14K ﹤0.01%
55
+26
+90% +$6.64K
JOAN
2778
DELISTED
JOANN, Inc. Common Stock
JOAN
$14K ﹤0.01%
+1,400
New +$15.6K
CALA
2779
DELISTED
Calithera Biosciences, Inc
CALA
$14K ﹤0.01%
299
-1,419
-83% -$82.6K
TXG icon
2780
10x Genomics
TXG
$7.14B
$13K ﹤0.01%
73
-24,228
-100% -$4.18M
ELDN icon
2781
Eledon Pharmaceuticals
ELDN
$292M
$11K ﹤0.01%
+1,000
New +$15.1K
TIMB icon
2782
TIM SA
TIMB
$8.81B
$9K ﹤0.01%
818
-3,256
-80% -$39.9K
TRIT
2783
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$9K ﹤0.01%
+1,201
New +$9.78K
WORK
2784
DELISTED
Slack Technologies, Inc.
WORK
$9K ﹤0.01%
218
-1,013
-82% -$42.4K
ALXN
2785
DELISTED
Alexion Pharmaceuticals
ALXN
$8K ﹤0.01%
51
-45,351
-100% -$7.02M
FHS
2786
DELISTED
First High-School Education Group Co., Ltd. American Depositary Shares (each representing three (3) Class A Ordinary Shares)
FHS
$7K ﹤0.01%
+1,007
New +$7.1K
KROS icon
2787
Keros Therapeutics
KROS
$215M
$6K ﹤0.01%
100
-100
-50% -$6.34K
IPHI
2788
DELISTED
INPHI CORPORATION
IPHI
$6K ﹤0.01%
33
-24,843
-100% -$4.15M
CERE
2789
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$5K ﹤0.01%
400
-11,725
-97% -$172K
GRSV
2790
DELISTED
Gores Holdings V, Inc.
GRSV
$5K ﹤0.01%
+500
New +$5.26K
CNTB
2791
Connect Biopharma Holdings
CNTB
$138M
$4K ﹤0.01%
+200
New +$3.4K
KRYS icon
2792
Krystal Biotech
KRYS
$9.71B
$4K ﹤0.01%
+48
New +$3.49K
SST icon
2793
System1
SST
$17.7M
$4K ﹤0.01%
+37
New +$3.95K
ORPH
2794
DELISTED
Orphazyme A/S
ORPH
$4K ﹤0.01%
+490
New +$6.03K
IMUX icon
2795
Immunic
IMUX
$194M
$3K ﹤0.01%
+18
New +$3.05K
OSCR icon
2796
Oscar Health
OSCR
$8.78B
$3K ﹤0.01%
+100
New +$3.13K
SEMR
2797
DELISTED
Semrush
SEMR
$2K ﹤0.01%
+200
New +$2.32K
TARO
2798
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2K ﹤0.01%
+25
New +$1.9K
OWL icon
2799
Blue Owl Capital
OWL
$18.4B
$1K ﹤0.01%
+55
New +$570
RLMD icon
2800
Relmada Therapeutics
RLMD
$511M
$1K ﹤0.01%
29
-595
-95% -$20.8K
110 111
112
113 114

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2021 Portfolio in Review

As of Q1 2021, Cubist Systematic Strategies held 3,067 positions worth $7.81B, up 7.4% from $7.27B the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

Cubist Systematic Strategies's Q1 2021 filing shows 528 new, 1,137 increased, 1,133 reduced and 263 closed positions. Its largest new stake was PhenomeX Inc. Common Stock: 210,710 shares worth $10.6M. The largest sale was Danaher, an estimated $36M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Cubist Systematic Strategies's largest Q1 2021 buy was PhenomeX Inc. Common Stock: 210,710 shares worth $10.6M.
  • Cubist Systematic Strategies added most to Aptiv in Q1 2021, an estimated $48.4M increase.
  • Cubist Systematic Strategies's biggest Q1 2021 reduction was Danaher, cutting an estimated $36M.
  • Cubist Systematic Strategies fully exited American Tower in Q1 2021, selling an estimated $19.5M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.7% of its $7.81B portfolio in Q1 2021.
  • Cubist Systematic Strategies opened 528 new positions and closed 263 in Q1 2021.
  • Cubist Systematic Strategies's portfolio value rose 7.4% quarter-over-quarter to $7.81B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.